Autocrine Growth of Human B Lymphocytes: Maintained Response to Autostimulatory Factors is the Special Feature of Immortalization by Epstein-Barr Virus--a Hypothesis
Overview
Pharmacology
Affiliations
The autocrine growth profile of human B lymphocytes transformed with Epstein-Barr virus (EBV) was found to comprise three distinct components: a B-cell growth factor (BCGF); an interleukin-1 (IL-1)-like activity; an activity requiring cell-to-cell contact for its action. Observations on the inhibition of the EBV-carrying Daudi lymphoma line by alpha-interferon indicated that loss of response to these autostimulatory factors was underlying growth cessation. Furthermore, a putative receptor for BCGF was found to be down-regulated on B cells stimulated with non-transforming mitogens but constitutively expressed following EBV-transformation. Taken together with recent evidence that normal B cells produce autostimulatory factors, these findings suggest that the special feature of autocrine growth by EBV-immortalized cells is a maintenance of what should normally be a transient phenotype, possibly through deregulation of receptor expression. This hypothesis is discussed.
Smith A, Howard P, Shah S, Eriksson P, Stender S, Giambartolomei C PLoS Genet. 2012; 8(8):e1002908.
PMID: 22916038 PMC: 3420950. DOI: 10.1371/journal.pgen.1002908.
Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.
Tosato G, Teruya-Feldstein J, Setsuda J, Pike S, Jones K, Jaffe E Springer Semin Immunopathol. 1998; 20(3-4):405-23.
PMID: 9870254 DOI: 10.1007/BF00838052.
Lahat N, AGHAI E, Maroun B, Kinarty A, Quitt M, Froom P Clin Exp Immunol. 1991; 85(2):302-6.
PMID: 1864011 PMC: 1535733. DOI: 10.1111/j.1365-2249.1991.tb05723.x.